Whole genome analysis of influenza A(H3) viruses detected between 2016-2018 in the scope of EuroEVA/I-MOVE vaccine effectiveness study

Pedro Pechirra(National Institute of Health Dr. Ricardo Jorge), Raquel Guiomar, Verónica Gomez(National Institute of Health Dr. Ricardo Jorge), Paula Cristóvão(Instituto Nacional de Investigação Agrária e Veterinária), Vítor Borges(National Institute of Health Dr. Ricardo Jorge), Ana Paula Rodrigues(Microsoft (Brazil)), João Paulo Gomes(National Institute of Health Dr. Ricardo Jorge), Ausenda Machado(National Institute of Health Dr. Ricardo Jorge), Inês Costa, Patrícia Conde(National Institute of Health Dr. Ricardo Jorge), Baltazar Nunes(University of Lisbon), Irina Kislaya(German Center for Infection Research)
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
November 23, 2018
Cited by 0

Related Papers

Ambient Particulate Air Pollution and Daily Mortality in 652 Cities
|New England Journal of Medicine|2019|1.7k
Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus
|PLoS Biology|2022|350
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303
Short term associations of ambient nitrogen dioxide with daily total, cardiovascular, and respiratory mortality: multilocation analysis in 398 cities
|BMJ|2021|254
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238